Prof. Dr. Maria J. Troulis is a professor and a surgeon–scientist at the MGH/MGB and HSDM/HMS. Troulis earned her degrees and completed residencies at McGill U in Canada, followed by a fellowship in Pediatric CMF Surgery, at MGH/MGB/Harvard, USA. She has changed the face of clinical OMFS by pioneering the use of MIS. As a translational scientist, Troulis leads teams on research regarding rare tumors, i.e., CCOC and CCC of the salivary glands (August 2003, Guastaldi 2019, Desai 2021, Rivera
2021, Weil 2022). These tumors have translocations in the EWSR1::CREB1 gene fusion family of transcription factors (core group comprising Dr. Troulis, Dr. Faquin, Dr. Iafrate, Dr. Rivera, and Dr. Ben Peled). Understanding these tumors, providing target treatment with small molecules, and radiation-sparing in the long-term surveillance are the goals of her research.
Prof. Dr. Maria J. Troulis is a professor and a surgeon–scientist at the MGH/MGB and HSDM/HMS. Troulis earned her degrees and completed residencies at McGill U in Canada, followed by a fellowship in Pediatric CMF Surgery, at MGH/MGB/Harvard, USA. She has changed the face of clinical OMFS by pioneering the use of MIS. As a translational scientist, Troulis leads teams on research regarding rare tumors, i.e., CCOC and CCC of the salivary glands (August 2003, Guastaldi 2019, Desai 2021, Rivera
2021, Weil 2022). These tumors have translocations in the EWSR1::CREB1 gene fusion family of transcription factors (core group comprising Dr. Troulis, Dr. Faquin, Dr. Iafrate, Dr. Rivera, and Dr. Ben Peled). Understanding these tumors, providing target treatment with small molecules, and radiation-sparing in the long-term surveillance are the goals of her research.